Viewing nowExome 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

MFDS item code 201902733 · Approved 2019.04.29 · Insurance code 073001460
Treatment and prevention of acid-related disorders, Helicobacter pylori infection, ulcers and rebleeding, and gastrointestinal disorders caused by nonsteroidal anti-inflammatory drugs
This drug is used to treat gastroesophageal reflux disease and erosive esophagitis, and is effective for long-term maintenance therapy to prevent recurrence in esophagitis patients. It also helps alleviate symptoms of gastroesophageal reflux disease without esophagitis. Included in antibiotic combination therapy for the eradication of Helicobacter pylori, it contributes to the treatment and prevention of recurrence of duodenal and peptic ulcers. It is effective for the treatment of upper gastrointestinal symptoms and gastric ulcers associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) and for the prevention of related ulcers. It is also used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after preventing rebleeding from gastric or duodenal ulcers, improving the patient's condition.
1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for the eradication of Helicobacter pylori Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective and selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continued treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with the use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration. 4. Renal impairment No dose adjustment is necessary. Since there is limited experience with administration to patients with severe renal failure, this medicine should be administered with caution. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not receive a dose of this medicine exceeding 20 mg. 6. Older adults No dose adjustment is necessary.
Adolescents 12 years of age and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Adolescents 12 years of age and older - Pediatric patients under 12 years of age: There is no experience with administering this medicine to pediatric patients under 12 years of age.
This drug should not be administered to certain patients. For example, individuals with hypersensitivity to this drug or any of its components, or those who have had such reactions in the past, should not take this drug. Additionally, patients with allergies to penicillin and macrolide antibiotics should not use this drug when combined with amoxicillin or clarithromycin for Helicobacter pylori eradication therapy. This drug should also not be administered to patients with certain heart diseases, nursing mothers, or patients taking certain antiviral drugs (e.g., atazanavir, nelfinavir, rilpivirine). Caution is necessary as various adverse reactions may occur while taking this drug. Common adverse reactions include headache, abdominal pain, diarrhea, constipation, nausea, and vomiting. Rarely, blood abnormalities, hypomagnesemia, confusion, allergic reactions, liver function abnormalities, skin rashes, myalgia, may occur. Particularly with long-term use, electrolyte abnormalities such as hypomagnesemia may appear, necessitating regular blood tests. This drug suppresses gastric acid secretion, thereby increasing the risk of bacterial infections in the gastrointestinal tract. Additionally, long-term use may elevate the risk of fractures, so patients at risk of osteoporosis should exercise caution. This drug may interact with other medications, so especially when used with anticoagulants, anticonvulsants, antidepressants, antiviral drugs, and antibiotics, consultations with a physician or pharmacist are advised. Data on the safety of this drug during pregnancy are limited, thus pregnant women should consult a professional before taking this drug. Nursing women are advised not to take this drug. In cases of overdose, there is no specific antidote, and appropriate treatment should be sought according to the symptoms, keeping it out of reach of children in a safe place. This drug should be used only for the minimum necessary dose and duration, and it is important to immediately consult medical personnel if there are any changes in symptoms.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, sensory disturbance, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riehl's melanosis, acute generalized pustular psoriasis, eosinophilia, drug reaction with systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid nodules, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal motility disorder, upper abdominal pain, belching, esophageal disorder, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormality, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, spasms, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered sense of smell, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps, mucosal discoloration, fracture, myalgia, asthenia, rhabdomyolysis, lupus erythematosus, systemic lupus erythematosus, gastric adenomatous polyp, hypocalcemia, hypokalemia, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia and drug reaction with systemic symptoms, acute generalized pustular psoriasis
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also important to maintain a room temperature between 1°C and 30°C when storing the drug. This will help keep the drug effective for a long time.
Pink oval film-coated tablets
28 tablets (14 tablets/Alu-Alu*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.